Stephens & Co. Reiterates Overweight on Stoneridge, Maintains $27 Price Target
Stephens & Co. analyst Justin Long reiterates Stoneridge (NYSE:SRI) with a Overweight and maintains $27 price target.
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell
• Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Recap: Stoneridge Q2 Earnings
Stoneridge (NYSE:SRI) reported its Q2 earnings results on Wednesday, August 3, 2022 at 05:00 PM.
Here's what investors need to know about the announcement.
Earnings
Stoneridge missed estimated earnings by 38.1%, reporting an EPS of $-0.29 versus an estimate of $-0.21.
Top 15 Trending Stocks On WallStreetBets As Of Monday, July 11, 2022 (Via Swaggy Stocks)
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Tesla (TSLA)
Twitter (TWTR)
Apple (AAPL)
Amazon (AMZN)
ContextLogic (WISH)
ProShares Trust Ultra VIX Short Term Futures
Stoneridge Earnings Perspective: Return On Invested Capital
Benzinga Pro data, Stoneridge (NYSE:SRI) reported Q1 sales of $221.06 million. Earnings fell to a loss of $7.67 million, resulting in a 24.51% decrease from last quarter.
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Stoneridge Earnings Perspective: Return On Invested Capital
According to Benzinga Pro data, during Q4, Stoneridge (NYSE:SRI) posted sales of $203.70 million. Earnings were up 40.49%, but Stoneridge still reported an overall loss of $6.16 million.
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 109 companies set new 52-week lows.